Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04432207
Title A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Imugene Limited
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Mayo Clinic Phoenix Arizona 85054 United States Details
Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
Ohio State University Medical Center Columbus Ohio 43210 United States Details
Chris O'Brien Lifehouse Camperdown New South Wales 2050 Australia Details
Macquarie University Macquarie New South Wales 2109 Australia Details
Cabrini Malvern Hospital Melbourne Victoria 3000 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field